Abstract Many health professionals use large datasets to answer behavioral, translational, or clinical questions. Understanding the impact of missing data in large databases, such as disease registries, can avoid erroneous interpretations of these data. Using the California Cancer Registry, the authors selected seven common cancers, seven sociodemographic and clinical variables, and the top three reporting sources, as examples of the type of data that would be deemed critical to most studies. The gender variable had no missing data, followed by age (<0.1 % missing), ethnicity (1.7 %), stage (9.8 %), differentiation (39.1 %), and birthplace (41.1 %). Reports from hospitals and clinics had the lowest percentages of missing data. Users of large datasets should anticipate the limitations of missing data to prevent methodological flaws and misinterpretations of research findings. Knowledge of what and how much data may be missing in large datasets can help prevent errors in research conclusions, while better guiding treatment modalities and public health policies and programs.
Introduction
This paper quantifies missing data in a large, well-run, total population-based dataset for the purpose of documenting the magnitude of this problem and raising awareness of the inherent limitations that arise. Its purpose is not to suggest means for more completeness of data gathering, but to remind health educators that their students must be made aware of these limitations.
Explorations of large-scale databases are used to: (1) monitor changes in disease incidence and mortality, (2) develop public health interventions designed to make the best use of limited resources, (3) ground research foci and methodological approaches, (4) evaluate the impact of public health interventions on disease control, (5) make patient care management recommendations, (6) inform legislative and governmental policy agendas, and (7) focus philanthropic strategies. The value of a database depends upon its accuracy and completeness and an appreciation of its limitations. Creating a complete set of health-related data is particularly challenging because it requires busy health care providers to remember to collect and record key data, patients' willingness to relinquish the personal data to their health care providers, and abstractors' ability to find and discern these data quickly within patients' often complex medical records.
These missing data are a type of reporting bias in that they are not in the hospital chart, the doctor's office record, or the laboratory report. Users must be aware of how large numbers of cases with missing data can create datasets which are not necessarily representative of the population as a whole and, thus, can skew their results and conclusions. Hence, users of these datasets and the findings arising from them need to understand the potential for skewed results and incorporate such limitations when they consider potential applications of the findings.
Previous studies have not quantified the percentages of missing data from the in-depth database users' perspective. For this study, "missing data" are defined as those which the California Cancer Registry (CCR) coded as "unknown," "unspecified," or "absent" data. It was hypothesized that there were considerable variations in the percentages of missing sociodemographic and clinical data in the CCR among the seven most common cancers, as well as among reporting sources.
Materials and Methods
The CCR was explored as an example of a well-run registry to help users of such databases understand some of their key limitations. California law mandated that, as of 1988, all health care facilities, physicians, and laboratories operating in California must report their patients' cancer diagnoses to the CCR; there are penalties for not doing so. Only basal and squamous cancers of the skin, cancer in-situ of the uterine cervix, and a few tumors of borderline malignancy are currently exempted from this mandate. Thus the CCR is a statewide, total population-based registry that has gathered information from the entire state population ( For the purposes of this study, the seven most common cancers were selected: breast, prostate, lung, colorectal, gynecological, lymphoma/leukemia, and melanoma. Together they accounted for 75.4 % of the cases in the CCR (Table 1) .
Four sociodemographic variables (gender, age, ethnicity, and birthplace) and three clinical variables (diagnostic confirmation, stage, and differentiation) in the CCR were studied. "Diagnostic confirmation" was defined as the basis for confirming a cancer diagnosis: tissue examination, bone marrow examination, clinical findings, radiologic interpretation, and so forth. The percentages of missing data were recorded for each variable in relation to each cancer. Ethnic groups included non-Hispanic White, Black, Hispanic, and Asian/Pacific Islander. Too few American Indians or Alaskan Natives were identified to allow analysis by these categories. The same was true for the subgroups that comprise the Asian/Pacific Islander classification. A similar argument could be made for the African, Hispanic, and Euro-White descendants were they to be broken into specific groups by country of origin or regions. Table 1 shows the frequency of reporting for each of the six sources that report cases to the CCR. The top three reporting sources (hospitals/clinics, non-hospital independent laboratories, and physicians' offices), which together contributed 98.7 % of cases to the CCR, were further analyzed to determine the percentages of data missing for each variable among the seven cancers. Data from nursing homes, autopsies only, and death certificates only cumulatively contributed only 1.3 % of cases and were not further analyzed. When subsequent data are submitted on a patient, the CCR treats them in a predetermined hierarchical order, with hospitals' and clinics' data being given precedence, followed by doctors' offices and laboratories.
Results

Sociodemographic Data
For the three sources of data and the four sociodemographic characteristics, gender was the only socioeconomic characteristic for which there were no missing data and, therefore, was not included in tabulations. For age, virtually no data were missing for the seven cancers (Table 2) . Ethnicity followed, with only 1.7 % missing. Birthplace was the most likely variable to be missing for all seven cancers, separately or combined (41.1 %). For six of the seven cancers, percentages of missing birthplace data ranged between 31.6 and 48.3 %; melanoma was the exception with an omission rate of 62.5 %.
When the completeness of data for the six remaining variables was examined by age at diagnosis, there was a frequent, albeit occasionally inconsistent, trend for increased incompleteness with increased age. Further, as age increased, fewer reports came from hospitals/clinics and more came from independent laboratories and physicians' offices. All ethnic groups examined showed a similar trend between increasing age and the distribution of cases among reporting sources.
Clinical Data
Of the clinical data examined, diagnostic confirmation had the least data missing, ranging from 0.3 to 3.4 % for separate cancers and 1.9 % for all seven cancers combined ( Table 2) . Examining the data missing by the stage of disease showed considerable variation among the seven cancers, with lung showing half again more missing stage data (12.8 %) over the next highest cancer's (prostate) missing data (8.8 %). The stage for the lymphoma/leukemia group is skewed because 98.1 % of leukemias are (correctly) included in the "remote" stage [1, 2] .
Differentiation had the highest rate of missing data, with 39.1 % of the data missing for all seven cancers combined. The percentages of missing differentiation data varied greatly among the seven cancers, with 99.1 % of the melanoma differentiation data missing. In contrast, prostate cancer had the lowest percentage of differentiation data missing (7.9 %). The latter may well be a result of the general acceptance of a uniform measure of differentiation-the Gleason score.
Missing Data by Reporting Sources for All Eight Cancers Combined
The top three reporting sources were examined to evaluate the degree of missing data for each of the variables among the seven cancers being studied. Hospitals/clinics had the least missing data for each of the seven variables and for all seven cancers combined (Table 3) . Specifically, hospitals/clinics had very low percentages of missing data for age, ethnicity, and diagnosis confirmation; the percentages of missing data for birthplace was 40.0 % and for differentiation, 36.5 %. Physicians' offices had greater amounts of missing data for all seven variables compared to hospitals/clinics. Particularly noteworthy was the 64.6 % missing data for birthplace and the 70.5 % missing data for differentiation (Table 4) .
Hospital/clinics outperformed the two other reporting sources in completion of data. Comparing all three reporting sources, physicians' offices had the most missing data for differentiation (70.5 %) and diagnostic confirmation (9.4 %). Independent laboratories reports had the highest percentages of missing data for ethnicity (38.0 %), birthplace (77.3 %), and stage (29.8 %) for all seven cancers combined ( Table 5 ).
Given that birthplace was the most frequently missing variable, the authors examined the registry in search of a better source for these data. When data for living patients and deceased patients were compared, significantly more dead patients (72.4 %) than living patients (49.2 %) had birthplace data present. This difference is most likely the result of requiring this information on death certificates. For a point of comparison, the authors made multiple analyses to assess the proportions of missing data in SEER. Findings in SEER were similar to CCR.
Discussion
This examination of the completeness of an exceptionally well-run, large dataset provides examples of some of the pitfalls of which users need to be aware. As these data show, even in an optimally well-run registry, there will be limitations due to incompleteness of the data. While many researchers will work with datasets of this caliber, others will have to rely upon datasets gathered under less optimal circumstances. Educators of tomorrow's clinical researchers can help future researchers to avoid needless analytic errors by helping them to understand the limits of large datasets, as well as their potential for meaningful scientific discovery. The authors offer several points for educators to address when training future researchers on the use of large datasets.
These limits include adequacy, accuracy, completeness, nature of the reporting sources [3] [4] [5] [6] [7] [8] , and other measures of the quality of the data. Reporting sources vary widely in the completeness of the data which they submit. Site-specific measures such as stage or differentiation will affect the completeness and reproducibility of data recording. Perhaps most important is knowledge of how these missing data may affect, and possibly negate, any statistical analysis.
As hypothesized, this report has shown considerable variation in the percentages of missing sociodemographic and clinical data in the CCR among reporting sources and seven cancers. Our findings resembled the problems with missing SEER data discussed previously by Mettlin et al. in an analysis of cancer patients diagnosed in 1992 [9] and recently confirmed in this paper. While central registries such as CCR are example of optimal datasets, these issues become of even greater importance for researchers who must work with less optimal datasets.
The researcher needs to be aware of the actual reporting sources for the database. The analysis of the information in the CCR demonstrates the need for caution, since discrepancies were observed when cancer data were examined by reporting source. For example, in the CCR, incomplete reporting was more prevalent in independent laboratories than in physicians' offices or hospitals/clinics. These results suggest that different reporting sources may be following different protocols and have different standards. The laboratories reporting to CCR may have received only the data minimally needed for laboratory purposes from the physicians' offices on the laboratory requisition form. Similarly, another challenge to using data gathered from diverse resources is that different procedural requirements may be in place at the various sources of the information. This may occur in the CCR, for example, when data are gathered from laboratories outside of California, where procedures may be different.
Conclusions
This study demonstrates the need for users of large datasets to be aware of their possible limitations to avoid methodological flaws and misinterpretations of research findings. Research educators need to include the concepts presented in this paper when training future researchers, so that discoveries that arise from the use of datasets are as accurate as possible. Failure to anticipate and correct the flaws in datasets may lead to incorrect treatment modalities, as well as inappropriate public health policies based on these incorrect findings.
